Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urs Heilbronner

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|May 9, 2014
Variant GADL1 and response to lithium in bipolar I disorder, Liping Hou, Urs Heilbronner, et al.
G3 (Bethesda, Md.)|March 7, 2025
Aggregating single nucleotide polymorphisms improves filtering for false-positive associations postimputationKatharina Stahl, Sergi Papiol, Monika Budde, et al.
BMC Psychiatry|April 1, 2026
Reliability and validity of the Kurdish version of the patient health questionnaire-15 in a trauma-affected populationIbrahim Mohammed, Hataw Ahmed Sharif, Jan Kizilhan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 20, 2025
The impact of collider bias on genetic prediction in psychotic disordersAmna Asim, Yuan Yang, , et al.
Psychiatric Genetics|April 21, 2016
Effect of copy number variant burden on Global Assessment of Functioning in schizophreniaUrs Heilbronner, Katrin Gade, Stefan Herms, et al.
Der Nervenarzt|June 23, 2025
[Genetically informed treatment in psychiatry: new dynamics through APOE and antibody treatment of Alzheimer's disease]Daniel J Müller, Christine M Freitag, Urs Heilbronner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2025
Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysisNatalia E Fares-Otero, Monika Budde, Jonathan Laatsch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 23, 2025
Reply to the commentary on "Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis"Natalia E Fares-Otero, Monika Budde, Jonathan Laatsch, et al.
Frontiers in Genetics|December 23, 2022
Kalpra: A kernel approach for longitudinal pathway regression analysis integrating network information with an application to the longitudinal PsyCourse StudyBernadette Wendel, Markus Heidenreich, Monika Budde, et al.
Psychopharmacology|February 24, 2005
Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depressionBoldizsár Czéh, Olga Pudovkina, Marieke G C van der Hart, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|May 9, 2014
Variant GADL1 and response to lithium in bipolar I disorder, Liping Hou, Urs Heilbronner, et al.
G3 (Bethesda, Md.)|March 7, 2025
Aggregating single nucleotide polymorphisms improves filtering for false-positive associations postimputationKatharina Stahl, Sergi Papiol, Monika Budde, et al.
BMC Psychiatry|April 1, 2026
Reliability and validity of the Kurdish version of the patient health questionnaire-15 in a trauma-affected populationIbrahim Mohammed, Hataw Ahmed Sharif, Jan Kizilhan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 20, 2025
The impact of collider bias on genetic prediction in psychotic disordersAmna Asim, Yuan Yang, , et al.
Psychiatric Genetics|April 21, 2016
Effect of copy number variant burden on Global Assessment of Functioning in schizophreniaUrs Heilbronner, Katrin Gade, Stefan Herms, et al.
Der Nervenarzt|June 23, 2025
[Genetically informed treatment in psychiatry: new dynamics through APOE and antibody treatment of Alzheimer's disease]Daniel J Müller, Christine M Freitag, Urs Heilbronner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2025
Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysisNatalia E Fares-Otero, Monika Budde, Jonathan Laatsch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 23, 2025
Reply to the commentary on "Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis"Natalia E Fares-Otero, Monika Budde, Jonathan Laatsch, et al.
Frontiers in Genetics|December 23, 2022
Kalpra: A kernel approach for longitudinal pathway regression analysis integrating network information with an application to the longitudinal PsyCourse StudyBernadette Wendel, Markus Heidenreich, Monika Budde, et al.
Psychopharmacology|February 24, 2005
Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depressionBoldizsár Czéh, Olga Pudovkina, Marieke G C van der Hart, et al.
Pageof 12